Posting of Annual Report and

RNS Number : 9564B

Epistem Holdings plc

04 November 2009

 

For release: 4 November 2009

Epistem Plc 

("Epistem" or the "Company")

Posting of Annual Report and Accounts

Epistem Plc (LSE: EHP), the rapidly growing UK biotechnology company with adult epithelial stem cell expertise in oncology, gastrointestinal and dermatological diseases, confirms that its Annual Report and Accounts for the year ended 30 June 2009 and notice of AGM were posted to shareholders on 2 November 2009. 

An electronic copy of the Annual Report and Accounts is available on the Investor Centre section of the Company's website, www.epistem.co.uk.

For further details, please contact:

Epistem Plc

Matthew Walls CEO                          [phone]

John Rylands CFO

Piper Jaffray Ltd.

Neil Mackison, Graeme Smethurst      [phone]

Corporate Broking: Jamie Adams

Mike Wort / Anna Dunphy                  [phone]

De Facto Communications

About Epistem:

Epistem is a biotechnology company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal diseases, dermatology and ageing. Epistem provides specialised pre-clinical efficacy testing, biomarker services and develops proprietary novel therapeutics for partnership and development with drug development companies.

 

END

 

 

ACSZGMGMDDRGLZM